Tumor cell intrinsic SETD2-H3K36me3 loss increases PI3K–AKT signaling, leading to robust expression of CXCL1 and GM-CSF, that together recruit neutrophils and reprogram them to be immunosuppressive [109]. The gene discussed is CXCL1; the disease is neoplasm.